CANDER, S. Et Al. 2014. Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center. PRIMARY CARE DIABETES , vol.8, no.3 , 256-264.

CANDER, S., Dizdar, O. S., ÖZ GÜL, Ö., Guclu, M., Unal, O. K., Tuncel, E., ... ERTÜRK, E.(2014). Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center. PRIMARY CARE DIABETES , vol.8, no.3, 256-264.

CANDER, SONER Et Al. "Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center," PRIMARY CARE DIABETES , vol.8, no.3, 256-264, 2014

CANDER, SONER Et Al. "Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center." PRIMARY CARE DIABETES , vol.8, no.3, pp.256-264, 2014

CANDER, S. Et Al. (2014) . "Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center." PRIMARY CARE DIABETES , vol.8, no.3, pp.256-264.

@article{article, author={SONER CANDER Et Al. }, title={Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center}, journal={PRIMARY CARE DIABETES}, year=2014, pages={256-264} }